RE: The Duracell Bore strikes again . . . and again8 Nov 2022 13:42
Jack, " Nothing wrong with that but it does skew you're outlook as you want to the SP to drop so you can buy back and sell at a higher price, again nothing wrong with that and good luck to you. But the thing that riles most people is you're constant doubting and belittling any achievments/ milestones that are being hit as in dose escalation."
This is illogical. If I buy the shares (And how many posts have I made recently saying I have bought the shares!) then why would I want them to fall?
Its this unfounded misconception that one, I want the stock to fall (I don't, I would happy nay delighted if it were 1000p per share) and two, we are back to this ludicrous idea that i can affect the SP!!!!
The Sp is only 130p even though it was 120p over 2 years ago, even though it is 15 months into a trial with the results soon to be released/updated.
You have Paul Hill banging on about it with a bigger following than here, you have Myles with a bigger following than on here and they don't move the dial, so please believe me when I say, whatever is posted here does not affect the SP. Otherwise it would already be 1000p with the bullish and well researched posts out lining the potential on this BB.
Trading does not "skew" my outlook. I take a shorter term view as being more easily predictable in the events that might unfold. Trying to guess where AVCT will be in its developments in 2, 3 or 5 years times seems too vague, there are too many possibilities and permutations for me to try and predict what is most likely. So then for me, its just a pie in the sky .
As for belittling any achievments/ milestones that are being hit as in dose escalation, what do you mean? What do you know that I don't?
Are you are assuming based on the info given that it is behaving exactly as it did in the pre-clinical trials?
Well, i am assuming its working in the sense its not harming the patients because it would have been stopped. other than that I have no sense as to how well its level of efficacy is right now. But this comes back to the company and the SP.
The trial will take care of itself. It will work or fail, it will work either spectacularly well, or just a bit of improvement. Thats all down to the clever bods at AVCT.
What I try to see if there is a disconnect between the SP and the market.
I posted earlier that it was an absolute no-brainer to buy stock at 100p when the 95p offer came in (and explained why, according to my reasoning). Thats what i mean between focussing on the SP rather than the company. As a result on that purchase alone, I am 30% up.
But somehow this offends many here.